Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

BUY
$323.56 - $373.36 $15,854 - $18,294
49 Added 4.52%
1,132 $422,000
Q4 2022

Feb 14, 2023

BUY
$248.67 - $334.17 $28,845 - $38,763
116 Added 12.0%
1,083 $357,000
Q3 2022

Nov 14, 2022

SELL
$263.81 - $337.27 $2,110 - $2,698
-8 Reduced 0.82%
967 $255,000
Q2 2022

Aug 15, 2022

BUY
$301.4 - $428.42 $904 - $1,285
3 Added 0.31%
975 $305,000
Q1 2022

May 11, 2022

BUY
$379.46 - $424.54 $12,142 - $13,585
32 Added 3.4%
972 $406,000
Q4 2021

Feb 14, 2022

SELL
$373.53 - $434.12 $747 - $868
-2 Reduced 0.21%
940 $394,000
Q3 2021

Nov 15, 2021

BUY
$396.76 - $455.92 $13,093 - $15,045
33 Added 3.63%
942 $389,000
Q1 2021

May 17, 2021

BUY
$357.26 - $392.57 $25,722 - $28,265
72 Added 8.6%
909 $349,000
Q4 2020

Feb 11, 2021

SELL
$319.05 - $363.32 $1,914 - $2,179
-6 Reduced 0.71%
837 $304,000
Q3 2020

Nov 13, 2020

BUY
$280.08 - $347.78 $1,680 - $2,086
6 Added 0.72%
843 $284,000
Q2 2020

Aug 14, 2020

SELL
$270.93 - $320.3 $65,835 - $77,832
-243 Reduced 22.5%
837 $237,000
Q1 2020

May 13, 2020

BUY
$243.44 - $359.98 $2,921 - $4,319
12 Added 1.12%
1,080 $298,000
Q4 2019

Feb 14, 2020

BUY
$281.18 - $322.05 $7,873 - $9,017
28 Added 2.69%
1,068 $343,000
Q3 2019

Nov 12, 2019

BUY
$294.25 - $341.49 $12,652 - $14,684
43 Added 4.31%
1,040 $309,000
Q2 2019

Aug 12, 2019

BUY
$279.29 - $336.89 $17,874 - $21,560
64 Added 6.86%
997 $336,000
Q1 2019

May 15, 2019

BUY
$246.18 - $297.25 $9,601 - $11,592
39 Added 4.36%
933 $276,000
Q4 2018

Feb 14, 2019

BUY
$232.7 - $281.66 $7,213 - $8,731
31 Added 3.59%
894 $228,000
Q2 2018

Aug 13, 2018

BUY
$217.98 - $237.23 $188,116 - $204,729
863 New
863 $203,000
Q4 2017

Feb 13, 2018

SELL
$217.88 - $244.43 $193,695 - $217,298
-889 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$231.6 - $253.39 $205,892 - $225,263
889
889 $211,000

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Veritable, L.P. Portfolio

Follow Veritable, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Veritable, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Veritable, L.P. with notifications on news.